AAAAAA
Results: 1-25/49
Authors:
Degos, F
Pol, S
Chaix, ML
Laffitte, V
Buffet, C
Bernard, PH
Degott, C
Carnot, F
Riffaud, PC
Chevret, S
Citation: F. Degos et al., The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study, NEPH DIAL T, 16(5), 2001, pp. 1017-1023
Authors:
Pol, S
Citation: S. Pol, Management of hepatitis C viral infection in HIV-positive patients taking antiretroviral treatment, PRESSE MED, 30(14), 2001, pp. 677-682
Authors:
Pol, S
Citation: S. Pol, Hepatitis C virus and human immunodeficiency virus co-infection, GASTRO CL B, 25(4), 2001, pp. B152-B156
Authors:
Pol, S
Fontaine, H
Vallet-Pichard, A
Citation: S. Pol et al., Synopsis: Treatments for hepatitis virus C infections, GASTRO CL B, 25(3), 2001, pp. 289-301
Authors:
Brechot, C
Thiers, V
Kremsdorf, D
Nalpas, B
Pol, S
Paterlini-Brechot, P
Citation: C. Brechot et al., Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"?, HEPATOLOGY, 34(1), 2001, pp. 194-203
Authors:
Michel, ML
Pol, S
Brechot, C
Tiollais, P
Citation: Ml. Michel et al., Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future, VACCINE, 19(17-19), 2001, pp. 2395-2399
Authors:
Fontaine, H
Pol, S
Citation: H. Fontaine et S. Pol, Prevention and treatment of viral hepatitis in renal failure, NEPHROLOGIE, 22(7), 2001, pp. 339-347
Authors:
Pol, S
Citation: S. Pol, HBV and HCV infections in nephrology, NEPHROLOGIE, 22(6), 2001, pp. 321-322
Authors:
Nalpas, B
Martin, S
Fontaine, H
Fabbro-Peray, P
Brechot, C
Pol, S
Citation: B. Nalpas et al., Impact of medical recommendations on alcohol consumption in HCV positive patients, J HEPATOL, 35(2), 2001, pp. 312-313
Authors:
Pol, S
Nalpas, B
Driss, F
Michel, ML
Tiollais, P
Denis, J
Brechot, C
Citation: S. Pol et al., Efficacy and limitations of a specific immunotherapy in chronic hepatitis B, J HEPATOL, 34(6), 2001, pp. 917-921
Authors:
Fontaine, H
Nalpas, B
Carnot, F
Brechot, B
Pol, S
Citation: H. Fontaine et al., Effect of pregnancy on chronic hepatitis C - Reply, LANCET, 357(9253), 2001, pp. 389-390
Authors:
Fontaine, H
Nalpas, B
Poulet, B
Carnot, F
Zylberberg, H
Brechot, C
Pol, S
Citation: H. Fontaine et al., Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C, HUMAN PATH, 32(9), 2001, pp. 904-909
Authors:
Fontaine, H
Pol, S
Citation: H. Fontaine et S. Pol, Side effects of interferon-alpha in treating hepatitis C virus infection, TRANSPLAN P, 33(3), 2001, pp. 2327-2329
Authors:
Soussan, P
Pol, S
Garreau, F
Brechot, C
Kremsdorf, D
Citation: P. Soussan et al., Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants, J GEN VIROL, 82, 2001, pp. 367-371
Authors:
Pol, S
Citation: S. Pol, Treatment of hepatitis C virus infection in dialysis patients, NEPH DIAL T, 15, 2000, pp. 46-48
Authors:
Pol, S
Nalpas, B
Bourliere, M
Couzigou, P
Tran, A
Abergel, A
Zarski, JP
Berthelot, P
Brechot, C
Citation: S. Pol et al., Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C, HEPATOLOGY, 31(6), 2000, pp. 1338-1344
Authors:
Pol, S
Michel, ML
Brechot, C
Citation: S. Pol et al., Immune therapy of hepatitis B virus chronic infection, HEPATOLOGY, 31(2), 2000, pp. 548-549
Authors:
Zylberberg, H
Nalpas, B
Pol, S
Brechot, C
Viard, JP
Citation: H. Zylberberg et al., Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?, AIDS, 14(13), 2000, pp. 2055-2055
Authors:
Zylberberg, H
Fontaine, H
Correas, JM
Carnot, F
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Dilated bile duct in patients receiving narcotic substitution - An early report, J CLIN GAST, 31(2), 2000, pp. 159-161
Authors:
Tuveri, R
Jaffredo, F
Lunel, F
Nalpas, B
Pol, S
Feray, C
Marcellin, P
Thibault, V
Delagneau, JF
Opolon, P
Scarpa, B
Brechot, C
Thiers, V
Citation: R. Tuveri et al., Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases, J HEPATOL, 33(1), 2000, pp. 121-127
Authors:
Zylberberg, H
Fontaine, H
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Triggering of acute alcoholic hepatitis by alpha-interferon therapy? - Reply, J HEPATOL, 32(5), 2000, pp. 873-873
Authors:
Fontaine, H
Nalpas, B
Carnot, F
Brechot, C
Pol, S
Citation: H. Fontaine et al., Effect of pregnancy on chronic hepatitis C: a case-control study, LANCET, 356(9238), 2000, pp. 1328-1329
Authors:
Fontaine, H
Chaix, ML
Lagneau, JL
Brechot, C
Pol, S
Citation: H. Fontaine et al., Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa, LANCET, 356(9223), 2000, pp. 41-41
Authors:
Pol, S
Samuel, D
Cadranel, JF
Legendre, C
Bismuth, H
Brechot, C
Kreis, H
Citation: S. Pol et al., Hepatitis and solid organ transplantation, TRANSPLAN P, 32(2), 2000, pp. 454-457
Authors:
Fontaine, H
Thiers, V
Chretien, Y
Zylberberg, H
Poupon, RE
Brechot, C
Legendre, C
Kreis, H
Pol, S
Citation: H. Fontaine et al., HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients, TRANSPLANT, 69(10), 2000, pp. 2090-2094